Magazine article Insight on the News

Short Supply Jeopardizes Anthrax Program

Magazine article Insight on the News

Short Supply Jeopardizes Anthrax Program

Article excerpt

The military's anthrax-vaccination program -- monitored by Insight since it was announced by officials who took a very hard line and court-martialed some personnel who refused to participate -- may be headed for the back burner. According to the Associated Press, the program may be suspended due to a dwindling inventory of vaccine. It appears that present supplies will sustain the controversial program only for another month or two.

The program could kick into gear again if the Food and Drug Administration, or FDA, certifies a manufacturing plant that is trying to gear up to handle the new demand. The FDA has shut down that plant, BioPort Corp., twice in the last year. BioPort was formed by Intervac, L.L.C., a company that, according to conservative columnist Phyllis Schlafly, is 22.5 percent owned by retired Adm. William J. Crowe, former chairman of the Joint Chiefs of Staff (see "Why Bioport Got a Shot in the Arm, Sept. 20, 1999). …

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.